<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>佰傲谷BioValley | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-17T12:00:58+08:00</updated>
  <subtitle>佰傲谷致力于打造一个垂直于生物制品领域的第三方平台。为生物制药企业提供品牌推广、技术咨询、项目交易、企业合作、人才培养等服务。为生物制药行业从业人员提供沟通交流、会议培训、工作求职、个人展示平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>结束20余年备胎生涯---诺华奥马珠单抗重磅接班人Ligelizumab现身台前</title>
    <updated>2021-01-17T10:20:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/NhK3Qu7ba9y9XhU0K18c7w</id>
    <link href="https://mp.weixin.qq.com/s/NhK3Qu7ba9y9XhU0K18c7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶点药讯44|纵览全球药物靶点动态</title>
    <updated>2021-01-17T10:20:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/PDjb94w1imXn9VcGOd0eng</id>
    <link href="https://mp.weixin.qq.com/s/PDjb94w1imXn9VcGOd0eng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年疫苗批签发总结：后疫情时代，疫苗行业迎来新机遇</title>
    <updated>2021-01-17T10:20:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/2yU9c3-tc_lCDMeHnj7ONw</id>
    <link href="https://mp.weixin.qq.com/s/2yU9c3-tc_lCDMeHnj7ONw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国际化布局下的创新工匠---恒瑞医药宣布子公司两项实体瘤的临床试验申请获批</title>
    <updated>2021-01-16T09:57:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/iekRDyu3TiywZI9Uschq0g</id>
    <link href="https://mp.weixin.qq.com/s/iekRDyu3TiywZI9Uschq0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>细胞培养基如何助力中国生物制药研发与生产</title>
    <updated>2021-01-15T10:40:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/ZKGp7hTPdljQrysHXsrmsw</id>
    <link href="https://mp.weixin.qq.com/s/ZKGp7hTPdljQrysHXsrmsw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>聚焦！2021初春领跑细胞基因免疫治疗技术！最新热点看这里！</title>
    <updated>2021-01-15T10:40:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/XlK0pt4q9UaMnJ8jGJ6akw</id>
    <link href="https://mp.weixin.qq.com/s/XlK0pt4q9UaMnJ8jGJ6akw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>数十亿美元的市场争夺--下一代肺炎球菌疫苗：默沙东15价 vs 辉瑞 20价 谁主场？</title>
    <updated>2021-01-15T10:40:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/z0JQJBjcqKDDkS286_Wwnw</id>
    <link href="https://mp.weixin.qq.com/s/z0JQJBjcqKDDkS286_Wwnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>必看！《治疗用生物制品病毒污染风险控制要点》新书发布会直播进行中！</title>
    <updated>2021-01-15T10:40:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/zI8mdxHEVX01zUypOXOL7g</id>
    <link href="https://mp.weixin.qq.com/s/zI8mdxHEVX01zUypOXOL7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Cytiva向龙沙 (Lonza) 交付模块化生物制品工厂</title>
    <updated>2021-01-14T17:03:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/S83SRQz9c5Uvrzz0OwsE3w</id>
    <link href="https://mp.weixin.qq.com/s/S83SRQz9c5Uvrzz0OwsE3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>JPM2021，第2天热闻：吉利德，默克，艾伯维，辉瑞等</title>
    <updated>2021-01-14T17:03:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/Pkni0JuykzqjaxcZ4yxsOg</id>
    <link href="https://mp.weixin.qq.com/s/Pkni0JuykzqjaxcZ4yxsOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>开年大吉，百济 PD-1 新适应症上市！系NSCLC领域首款国产PD-1药物</title>
    <updated>2021-01-14T17:03:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/2EgQKfdP7dmMBnTFY5Dg5Q</id>
    <link href="https://mp.weixin.qq.com/s/2EgQKfdP7dmMBnTFY5Dg5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年，这些中国生物科技公司在科创板上市</title>
    <updated>2021-01-13T11:27:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/BJJsMPg-TZRO4zxQ-U1-Jg</id>
    <link href="https://mp.weixin.qq.com/s/BJJsMPg-TZRO4zxQ-U1-Jg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>发展的元年：2021年度新锐公司榜，细胞/基因治疗占15席</title>
    <updated>2021-01-13T11:27:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/mCKXvwfM_KqupmVSr7ifFg</id>
    <link href="https://mp.weixin.qq.com/s/mCKXvwfM_KqupmVSr7ifFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恢复期患者血浆无助新冠重症患者康复</title>
    <updated>2021-01-13T11:27:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/MnyVKqmPrK70qxwvRbj6eg</id>
    <link href="https://mp.weixin.qq.com/s/MnyVKqmPrK70qxwvRbj6eg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>不再预留第二针，美当局调整疫苗免疫策略</title>
    <updated>2021-01-13T11:27:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/zfCIO7qpxdSV6SYl5uvpWQ</id>
    <link href="https://mp.weixin.qq.com/s/zfCIO7qpxdSV6SYl5uvpWQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再生元新冠中和抗体获超26亿美元大订单，2020年销售1.84亿美元</title>
    <updated>2021-01-13T11:27:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/ZeuowcSg6c21q6LiNCbAXw</id>
    <link href="https://mp.weixin.qq.com/s/ZeuowcSg6c21q6LiNCbAXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>股价大涨超17%，22亿美元！百济PD-1授权诺华创License out新纪录</title>
    <updated>2021-01-12T12:35:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/HWro2YXzELCevAOQQR5Lwg</id>
    <link href="https://mp.weixin.qq.com/s/HWro2YXzELCevAOQQR5Lwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“死亡之谷”的回音？礼来阿尔茨海默药物Donanemab二期临床成功</title>
    <updated>2021-01-12T12:35:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/JZqONDxGhnzFU4Y0phbLwg</id>
    <link href="https://mp.weixin.qq.com/s/JZqONDxGhnzFU4Y0phbLwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤相关中性粒细胞</title>
    <updated>2021-01-12T12:35:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/J6tFgTq1lc2ySWVmKR1uBw</id>
    <link href="https://mp.weixin.qq.com/s/J6tFgTq1lc2ySWVmKR1uBw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR技术的传承：CAR-NK、CAR-NKT、CAR-M、CAR-Treg</title>
    <updated>2021-01-11T12:03:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/N2_q_qoxDiFRxgPczKNzXQ</id>
    <link href="https://mp.weixin.qq.com/s/N2_q_qoxDiFRxgPczKNzXQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>